AbbVie Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest AbbVie careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Clinical Data Analyst **New** **USA, Illinois, Lake County** Research & Development Requisition #1809101 + Establishes standards to be used in the design and development of key system interfaces. + Supports th...
Posted: December 12, 2018, 5:44 am
TA Lead, Patient Recruitment & Retention, Gen Med/Neurology/Oncology **New** **USA, Massachusetts, Cambridge** 1 additional location USA, Massachusetts Research & Development Requisition #1809141 + ...
Posted: December 12, 2018, 5:44 am
Associate Clinical Operations Manager **New** **Republic of Serbia, Belgrade** 3 additional locations Republic of SerbiaRepublic of Serbia, Vojvodina, BelgradeRepublic of Serbia, Vojvodina Clinical Research ...
Posted: December 12, 2018, 5:44 am
Analyst, Clinical Safety **New** **USA, Illinois, Lake County** Research & Development Requisition #1809148 + Triages incoming SAE information in order to fulfill timely reporting according to the authority/regul...
Posted: December 12, 2018, 5:44 am
Database Engineer II (Oracle Developer) **New** **USA, Illinois, Lake County** Information Technology Requisition #1809157 The Data Solutions Department within the Information Research (IR) Division is building t...
Posted: December 12, 2018, 5:44 am

Viewing page 1 of 100|Next Page

  Newsfeed | Subscribe  

What's a 10-letter word that describes a waste of money that at one point had the appearance of adding value? Boondoggle. And the word could now apply to AbbVie's (NYSE:ABBV) $5.8 billion acquisition ...
Posted: December 11, 2018, 2:01 am
In the latest trading session, AbbVie (ABBV) closed at $87.59, marking a +0.72% move from the previous day. This change outpaced the S&P 500's 0.18% gain on the day. Meanwhile, the Dow gained 0.14 ...
Posted: December 10, 2018, 3:59 pm
Shares of AbbVie (NYSE: ABBV), the pharmaceutical company behind all those Humira advertisements, soared 21.1% in November, according to data from S&P Global Market Intelligence. The stock began ...
Posted: December 9, 2018, 1:34 pm
AbbVie has one of the highest dividend yields among the Dividend Aristocrats Index. Because of this as well as the patent expirations of the company's flagship drug Humira, some investors have ...
Posted: December 8, 2018, 1:34 am
AbbVie has experienced a number of setbacks over the last year, but the underlying company is performing better than the stock is letting on. Fundamentally, the company offers strong earnings ...
Posted: December 6, 2018, 11:30 am

Viewing page 1 of 3|Next Page